https://revistasangre.com/es/2022/editorial/ 2026-10-06T00:03:31+00:00 https://revistasangre.com/es/2023/lxv-congreso-nacional-de-la-sehh-xxxix-congreso-nacional-de-la-seth-iii-congreso-iberoamericano-de-hematologia/ 2026-10-06T00:03:31+00:00 https://revistasangre.com/es/2022/ictus-embolia-sistemica-y-sangrado-mayor-en-pacientes-con-tromboembolismo-venoso-durante-el-tratamiento-con-antagonistas-de-la-vitamina-k-resultados-del-estudio-eventho/ 2026-10-06T00:03:31+00:00 https://revistasangre.com/es/2022/asociacion-de-las-metaloproteasas-de-matriz-con-el-pronostico-en-pacientes-hospitalizados-por-covid-19/ 2026-10-06T00:03:31+00:00 https://revistasangre.com/es/2022/aplicacion-clinica-del-diagnostico-molecular-en-trastornos-mieloides-recomendaciones-para-implementar-una-estrategia-comun-en-los-centros-espanoles/ 2026-10-06T00:03:31+00:00 https://revistasangre.com/es/2022/diario-de-un-centro-de-transfusion-en-tiempos-de-covid-19/ 2026-10-06T00:03:31+00:00 https://revistasangre.com/es/2022/lxiv-congreso-nacional-de-la-sehh-xxxviii-congreso-nacional-de-la-seth-38th-world-congress-of-the-ish/ 2026-10-06T00:03:31+00:00 https://revistasangre.com/es/2022/lxiv-congreso-nacional-de-la-sehh-xxxviii-congreso-nacional-de-la-seth-38th-world-congress-of-the-ish-2/ 2026-10-06T00:03:31+00:00 https://revistasangre.com/es/2022/cambio-de-ibrutinib-a-venetoclax-en-la-leucemia-linfocitica-cronica-para-evitar-la-progresion-rapida-de-la-enfermedad-un-protocolo-de-transicion-basado-en-casos-clinicos/ 2026-10-06T00:03:31+00:00 https://revistasangre.com/es/2022/complicaciones-tromboticas-de-la-terapia-antineoplasica-en-pacientes-oncohematologicos-quimioterapia-y-tromboembolismo/ 2026-10-06T00:03:31+00:00 https://revistasangre.com/es/2022/recomendaciones-generales-del-grupo-espanol-de-citologia-hematologica-gech-para-la-valoracion-del-mielograma-y-la-realizacion-del-informe-citologico-de-medula-osea/ 2026-10-06T00:03:31+00:00 https://revistasangre.com/es/2022/el-sindrome-tempi-evolucion-y-respuesta-al-tratamiento-con-bortezomib-y-daratumumab/ 2026-10-06T00:03:31+00:00 https://revistasangre.com/es/2023/corrigendum/ 2026-10-06T00:04:39+00:00 https://revistasangre.com/es/2024/lxvi-congreso-nacional-sehh-xl-congreso-nacional-sethresumenes-de-comunicaciones/ 2026-10-06T00:05:19+00:00 https://revistasangre.com/es/2024/que-esperamos-de-la-terapia-car-t-en-mieloma/ 2026-10-06T00:05:19+00:00 https://revistasangre.com/es/2024/de-la-quimioterapia-a-la-inmunoterapia-en-la-leucemia-linfoblastica-aguda/ 2026-10-06T00:05:48+00:00 https://revistasangre.com/es/2024/mecanismos-de-resistencia-a-los-farmacos-hipometilantes/ 2026-10-06T00:05:48+00:00 https://revistasangre.com/es/2024/diagnostico-molecular-de-hiperferritinemia-hemocromatosis-hiperferritinemias-metabolicas-y-mas-alla/ 2026-10-06T00:05:48+00:00 https://revistasangre.com/es/2024/terapia-car-t-y-transfusion-de-plaquetas-un-reto-para-los-servicios-de-transfusion/ 2026-10-06T00:05:48+00:00 https://revistasangre.com/es/2024/generacion-de-un-registro-de-donantes-de-linfocitos-experiencia-del-redocel/ 2026-10-06T00:05:48+00:00 https://revistasangre.com/es/2024/aplicaciones-de-la-inteligencia-artificial-en-el-mieloma-multiple/ 2026-10-06T00:05:48+00:00 https://revistasangre.com/es/2024/inmunoterapia-en-amiloidosis-de-cadenas-ligeras-al/ 2026-10-06T00:06:19+00:00 https://revistasangre.com/es/2024/incorporacion-de-estudios-de-fragilidad-en-el-trasplante-de-progenitores-hematopoyeticos/ 2026-10-06T00:06:19+00:00 https://revistasangre.com/es/2024/el-diagnostico-diferencial-entre-las-neoplasias-mieloproliferativas-y-las-neoplasias-mieloproliferativas-mielodisplasicas-desde-un-punto-de-vista-de-diagnostico-hematologico/ 2026-10-06T00:06:19+00:00 https://revistasangre.com/es/2024/aspectos-moleculares-de-las-mutaciones-tp53-en-las-neoplasias-mieloides/ 2026-10-06T00:06:19+00:00 https://revistasangre.com/es/2024/incorporacion-de-nuevas-tecnologias-a-la-docencia-y-situacion-de-la-docencia-pregrado-en-hematologia-en-espana/ 2026-10-06T00:06:19+00:00 https://revistasangre.com/es/2024/situacion-actual-del-tratamiento-de-la-enfermedad-de-celulas-falciformes/ 2026-10-06T00:06:55+00:00 https://revistasangre.com/es/2024/diagnostico-y-tratamiento-de-los-linfomas-de-la-zona-marginal-en-la-era-de-las-terapias-dirigidas/ 2026-10-06T00:06:55+00:00 https://revistasangre.com/es/2024/no-todo-esta-dicho-en-la-leucemia-mieloide-cronica-es-importante-mantener-el-concepto-de-fase-acelerada/ 2026-10-06T00:06:55+00:00 https://revistasangre.com/es/2024/nuevos-retos-en-la-estudio-de-las-resistencias-en-pacientes-con-lmc/ 2026-10-06T00:06:55+00:00 https://revistasangre.com/es/2025/lxvii-congreso-nacional-de-la-sehh-xli-congreso-nacional-de-la-seth-resumenes-de-comunicaciones/ 2026-10-06T00:07:29+00:00 https://revistasangre.com/es/2025/neoplasias-hematologicas-con-predisposicion-germinal-un-reto-para-los-hematologos/ 2026-10-06T00:07:29+00:00 https://revistasangre.com/es/2025/ecosistema-de-datos-sanitarios-multiproposito-para-asistencia-gestion-e-investigacion-clinica/ 2026-10-06T00:07:58+00:00 https://revistasangre.com/es/2025/estrategia-terapeutica-del-paciente-con-leucemia-linfatica-cronica-en-recaida-o-refractariedad/ 2026-10-06T00:07:58+00:00 https://revistasangre.com/es/2025/eritropoyesis-en-hemoglobinopatias-y-talasemias/ 2026-10-06T00:07:58+00:00 https://revistasangre.com/es/2025/transformacion-de-la-asistencia-sanitaria-del-modelo-reactivo-a-uno-proactivo-en-un-contexto-de-hospital-sin-paredes/ 2026-10-06T00:08:31+00:00 https://revistasangre.com/es/2025/neoplasias-mieloproliferativas-en-ninos-y-en-adultos-jovenes-identificar-riesgos-y-necesidades/ 2026-10-06T00:08:31+00:00 https://revistasangre.com/es/2025/mieloma-multiple-de-muy-alto-riesgo/ 2026-10-06T00:08:31+00:00 https://revistasangre.com/es/2025/gestion-de-la-sangre-del-paciente-la-hematologia-ante-un-reto-inaplazable-en-la-medicina-personalizada/ 2026-10-06T00:09:09+00:00 https://revistasangre.com/es/2025/prevalencia-consecuencias-y-diagnostico/ 2026-10-06T00:09:09+00:00 https://revistasangre.com/es/2025/opciones-de-tratamiento-en-la-anemia-perioperatoria/ 2026-10-06T00:09:09+00:00 https://revistasangre.com/es/2022/volumen-41-numero-1/prevalencia-de-los-factores-de-riesgo-cardiovascular-lesion-de-organo-diana-y-enfermedad-cardiovascular-subclinica-y-sintomatica-en-una-cohorte-nacional-de-pacientes-con-leucemia-mieloide-cronica/ 2026-10-06T00:26:24+00:00 https://revistasangre.com/en/2022-en/volume-41-number-1/association-of-matrix-metalloproteinases-with-poor-prognosis-in-hospitalized-patients-with-covid-19/ 2026-10-06T14:55:22+00:00 https://revistasangre.com/en/2023-en/volume-42-number-2/corrigendum-2/ 2026-10-06T14:55:22+00:00 https://revistasangre.com/en/2022-en/volume-41-number-1/clinical-application-of-molecular-diagnostics-in-myeloid-disorders-recommendations-for-implementing-a-common-strategy-in-spanish-centers/ 2026-10-06T14:55:22+00:00 https://revistasangre.com/en/2022-en/volume-41-number-1/journal-of-a-transfusion-center-in-times-of-covid-19/ 2026-10-06T14:55:22+00:00 https://revistasangre.com/en/2022-en/volume-41-number-2/switching-from-ibrutinib-to-venetoclax-in-chronic-lymphocytic-leukemia-a-management-protocol-based-on-clinical-cases-avoiding-rapid-disease-progression/ 2026-10-06T14:55:22+00:00 https://revistasangre.com/en/2022-en/volume-41-number-2/thrombotic-complications-of-antineoplastic-therapy-in-oncohematological-patients/ 2026-10-06T14:55:22+00:00 https://revistasangre.com/en/2022-en/volume-41-number-2/grupo-espanol-de-citologia-hematologica-gech-recommendations-for-bone-marrow-aspirate-cytological-assessment-and-report/ 2026-10-06T14:55:22+00:00 https://revistasangre.com/en/2022-en/volume-41-number-2/the-tempi-syndrome-evolution-and-response-to-bortezomib-and-daratumumab-treatment/ 2026-10-06T14:55:22+00:00 https://revistasangre.com/en/2023-en/volume-42-number-1/value-contribution-of-olipudase-alfa-therapy-for-the-management-of-the-non-cns-manifestations-of-acid-sphingomyelinase-deficiency-by-multi-criteria-decision-analysis/ 2026-10-06T14:55:22+00:00 https://revistasangre.com/en/2023-en/volume-42-number-1/delphi-consensus-on-managing-prophylactic-treatment-in-patients-with-severe-hemophilia-a-in-spain/ 2026-10-06T14:55:22+00:00 https://revistasangre.com/en/2023-en/volume-42-number-1/genotype-phenotype-relationship-in-pyruvate-kinase-deficiency-baseline-transfusion-dependence-and-splenectomy-response/ 2026-10-06T14:55:22+00:00 https://revistasangre.com/en/2023-en/volume-42-number-1/delphi-consensus-on-recommendations-for-the-clinical-management-of-ph-acute-lymphoblastic-leukemia-patients/ 2026-10-06T14:55:22+00:00 https://revistasangre.com/en/2022-en/volume-41-number-1/editorial-2/ 2026-10-06T14:55:22+00:00 https://revistasangre.com/en/2022-en/volume-41-number-1/prevalence-of-cardiovascular-risk-factors-target-organ-damage-and-subclinical-and-symptomatic-cardiovascular-disease-in-a-national-population-of-patients-with-chronic-myeloid-leukemia/ 2026-10-06T14:55:22+00:00 https://revistasangre.com/en/2022-en/volume-41-number-1/stroke-systemic-embolism-and-major-bleeding-in-patients-with-venous-thromboembolism-during-vitamin-k-antagonist-treatment-results-from-the-event-ho-study/ 2026-10-06T14:55:22+00:00 https://revistasangre.com/en/2024-en/volume-43-supplement-2/the-tumor-microenvironment-in-aml/ 2026-10-06T14:56:14+00:00 https://revistasangre.com/en/2024-en/volume-43-supplement-2/toward-a-chemo-free-approach-for-follicular-lymphomas/ 2026-10-06T14:56:14+00:00 https://revistasangre.com/en/2024-en/volume-43-supplement-2/current-status-of-gene-therapy-in-hemoglobinopathies/ 2026-10-06T14:56:14+00:00 https://revistasangre.com/en/2024-en/volume-43-supplement-2/secondary-hemophagocytic-syndrome-in-adults-importance-diagnosis-and-management/ 2026-10-06T14:56:14+00:00 https://revistasangre.com/en/2025-en/volume-44-supplement-2/immunogenetics-of-allogeneic-hematopoietic-cell/ 2026-10-06T14:57:06+00:00 https://revistasangre.com/en/2025-en/volume-44-supplement-2/artificial-intelligence-in-the-diagnosis-of-hematologic-diseases/ 2026-10-06T14:57:06+00:00 https://revistasangre.com/en/2025-en/volume-44-supplement-2/genetic-landscape-and-cellular-hierarchy-of-acute-myeloid-leukemia/ 2026-10-06T14:57:06+00:00 https://revistasangre.com/en/2025-en/volume-44-number-2/patient-blood-management-hematology-facing-an-unpostponable-challenge-in-individualized-medicine/ 2026-10-06T14:57:06+00:00 https://revistasangre.com/es/2026/lxviii-congreso-nacional-de-la-sehhxlii-congreso-nacional-de-la-seth-resumenes-de-comunicaciones/ 2026-10-28T20:19:48+00:00 https://revistasangre.com/en/uncategorized-es-en/lxviii-national-congress-of-the-sehhxlii-national-congress-of-the-seth-abstracts-of-presentations/ 2026-10-28T20:20:38+00:00 https://revistasangre.com/es/2023/contribucion-de-valor-de-olipudase-alfa-en-el-tratamiento-de-las-manifestaciones-no-relacionadas-con-el-snc-del-deficit-de-esfingomielinasa-acida-mediante-analisis-de-decision-multicriterio/ 2026-10-28T20:29:12+00:00 https://revistasangre.com/es/2023/estudio-delphi-del-manejo-del-tratamiento-profilactico-en-pacientes-con-hemofilia-a-grave-en-espana/ 2026-10-28T20:34:23+00:00 https://revistasangre.com/es/2023/relacion-entre-genotipo-y-fenotipo-en-el-deficit-de-piruvato-quinasa-dependencia-transfusional-basal-y-respuesta-a-la-esplenectomia/ 2026-10-28T20:35:50+00:00 https://revistasangre.com/es/2023/consenso-delphi-de-las-recomendaciones-para-el-manejo-clinico-de-pacientes-con-leucemia-linfoblastica-aguda-con-cromosoma-filadelfia/ 2026-10-28T20:36:38+00:00 https://revistasangre.com/es/2023/estudio-epidemiologico-transversal-para-comprender-el-abordaje-del-tratamiento-en-la-atencion-habitual-de-pacientes-con-hemofilia-b-en-espana-y-portugal/ 2026-10-28T20:37:34+00:00 https://revistasangre.com/en/2023-en/volume-42-number-2/cross-sectional-epidemiological-study-to-understand-the-approach-to-treatment-in-the-routine-care-of-patients-with-hemophilia-b-in-spain-and-portugal/ 2026-10-28T20:37:52+00:00 https://revistasangre.com/es/2023/propuesta-de-modelo-integral-para-intervenciones-terapeuticas-paliativas-en-pacientes-con-micosis-fungoide-y-sindrome-de-sezary/ 2026-10-28T20:38:37+00:00 https://revistasangre.com/en/2023-en/volume-42-number-2/proposal-of-a-comprehensive-model-for-palliative-therapeutic-interventions-in-patients-with-mycosis-fungoides-and-sezary-syndrome/ 2026-10-28T20:38:48+00:00 https://revistasangre.com/es/2023/sindromes-hemofagociticos-vs-linfohistiocitosis-hemofagocitica/ 2026-10-28T20:39:45+00:00 https://revistasangre.com/en/2023-en/volume-42-number-2/hemophagocytic-syndromes-vs-hemophagocytic-lymphohistiocytosis/ 2026-10-28T20:39:52+00:00 https://revistasangre.com/es/2023/mapeo-optico-del-genoma-fundamentos-tecnologicos-y-aplicaciones-en-neoplasias-hematologicas/ 2026-10-28T20:41:16+00:00 https://revistasangre.com/en/2023-en/volume-42-number-2/optical-genome-mapping-technical-basis-and-applications-in-hematological-malignancies/ 2026-10-28T20:41:22+00:00 https://revistasangre.com/es/2023/avatrombopag-y-enfermedad-hepatica-cronica-a-proposito-de-un-paciente-con-hemofilia-a-grave/ 2026-10-28T20:42:11+00:00 https://revistasangre.com/en/2023-en/volume-42-number-2/avatrombopag-and-chronic-liver-disease-regarding-a-patient-with-severe-hemophilia-a/ 2026-10-28T20:42:17+00:00 https://revistasangre.com/es/2024/diagnostico-de-neutropenias-aportacion-de-los-estudios-moleculares-del-laboratorio-basico-a-la-practica-clinica/ 2026-10-28T20:43:44+00:00 https://revistasangre.com/es/2024/situacion-actual-de-la-amenaza-de-enfermedades-de-transmision-transfusional-por-patogenos-emergentes/ 2026-10-28T20:44:33+00:00 https://revistasangre.com/es/2024/anticuerpos-biespecificos-en-el-mieloma-multiple-en-recaida/ 2026-10-28T20:45:45+00:00 https://revistasangre.com/es/2024/neoplasias-mieloides-con-mutacion-de-tp53-aspectos-citologicos-e-inmunofenotipicos/ 2026-10-28T20:46:25+00:00 https://revistasangre.com/es/2024/sindromes-vasculares-endoteliales-en-el-trasplante-hematopoyetico/ 2026-10-28T20:47:00+00:00 https://revistasangre.com/es/2024/varon-de-20-anos-con-neutropenia-e-infecciones-de-repeticion/ 2026-10-28T20:47:38+00:00 https://revistasangre.com/es/2024/varon-de-56-anos-con-sindrome-anemico-y-esplenomegalia/ 2026-10-28T20:48:14+00:00 https://revistasangre.com/es/2024/leucocitosis-persistente-no-reactiva/ 2026-10-28T20:48:52+00:00 https://revistasangre.com/es/2024/nina-de-10-anos-con-masa-pelvica-y-trombocitopenia/ 2026-10-28T20:49:29+00:00 https://revistasangre.com/es/2024/nino-de-6-anos-con-megacarioblastosis-y-fenotipo-normal/ 2026-10-28T20:50:11+00:00 https://revistasangre.com/es/2024/mujer-de-77-anos-con-lumbalgia-astenia-y-plaquetopenia/ 2026-10-28T20:50:44+00:00 https://revistasangre.com/es/2024/prevencion-en-la-enfermedad-falciforme-diagnostico-prenatal-y-programa-de-cribado-neonatal-como-impactan-en-la-enfermedad/ 2026-10-28T20:51:20+00:00 https://revistasangre.com/es/2024/sindrome-linfoproliferativo-postrasplante-asociado-al-virus-de-epstein-barr-resultados-de-un-estudio-delphi-en-espana/ 2026-10-28T20:52:29+00:00 https://revistasangre.com/es/2024/neonato-de-36-horas-de-vida-con-insuficiencia-respiratoria-aguda-e-hipoglucemia/ 2026-10-28T20:53:20+00:00 https://revistasangre.com/es/2024/citopenias-persistentes-en-paciente-trasplantado-por-sindrome-mielodisplasico/ 2026-10-28T20:54:03+00:00 https://revistasangre.com/en/2024-en/volume-43-number-1/epstein-barr-virus-positive-post-transplant-lymphoproliferative-disease-results-of-a-delphi-study-in-spain/ 2026-10-28T20:54:46+00:00 https://revistasangre.com/en/2024-en/volume-43-number-1/36-hour-old-neonate-with-acute-respiratory-failure-and-hypoglycemia/ 2026-10-28T20:55:11+00:00 https://revistasangre.com/en/2024-en/volume-43-number-1/persistent-cytopenias-in-a-patient-transplanted-for-myelodysplastic-syndrome/ 2026-10-28T20:55:40+00:00 https://revistasangre.com/es/2024/mujer-de-74-anos-con-leucocitosis-y-sindrome-constitucional/ 2026-10-28T20:56:21+00:00 https://revistasangre.com/en/2024-en/volume-43-number-1/constitutional-syndrome-and-leukocytosis-in-a-woman-aged-74-years/ 2026-10-28T20:56:28+00:00 https://revistasangre.com/es/2024/varon-de-40-anos-con-faringoamigdalitis-resistente-a-antibioticos/ 2026-10-28T20:57:24+00:00 https://revistasangre.com/en/2024-en/volume-43-number-1/40-year-old-man-with-antibiotic-resistant-pharyngotonsillitis/ 2026-10-28T20:57:32+00:00 https://revistasangre.com/es/2024/varon-de-64-anos-con-sindrome-constitucional-y-pancitopenia/ 2026-10-28T20:58:16+00:00 https://revistasangre.com/en/2024-en/volume-43-number-1/64-year-old-male-with-constitutional-symptoms-and-pancytopenia/ 2026-10-28T20:58:21+00:00 https://revistasangre.com/es/2024/hombre-de-69-anos-con-anemia-y-esplenomegalia-gigante/ 2026-10-28T20:59:06+00:00 https://revistasangre.com/en/2024-en/volume-43-number-1/69-year-old-patient-with-anemia-and-massive-splenomegaly/ 2026-10-28T20:59:11+00:00 https://revistasangre.com/es/2024/cambio-a-concentrados-de-factor-viii-de-vida-media-prolongada-o-terapias-no-sustitutivas-en-pacientes-con-hemofilia-a-grave-o-moderada-sin-inhibidor-analisis-retrospectivo-experiencia-del-grupo-gall/ 2026-10-28T21:00:29+00:00 https://revistasangre.com/en/2024-en/volume-43-number-2/switching-to-extended-half-life-factor-viii-concentrates-or-non-factor-replacement-therapies-in-patients-with-severe-to-moderate-haemophilia-a-without-inhibition-retrospective-analysis-experience-of/ 2026-10-28T21:00:35+00:00 https://revistasangre.com/es/2024/impacto-economico-de-la-secuenciacion-de-tratamientos-con-terapias-orales-para-la-leucemia-linfocitica-cronica-en-espana/ 2026-10-28T21:01:19+00:00 https://revistasangre.com/en/2024-en/volume-43-number-2/economic-impact-of-sequencing-treatments-with-oral-therapies-for-chronic-lymphocytic-leukemia-in-spain/ 2026-10-28T21:01:24+00:00 https://revistasangre.com/es/2024/epidemiologia-y-manejo-clinico-de-pacientes-adultos-con-hemofilia-a-grave-sin-antecedentes-de-inhibidores-del-fviii-en-espana-resultados-de-un-estudio-delphi/ 2026-10-28T21:02:09+00:00 https://revistasangre.com/en/2024-en/volume-43-number-2/epidemiology-and-clinical-management-of-adult-patients-with-severe-hemophilia-a-without-a-history-of-fviii-inhibitors-in-spain-results-from-a-delphi-study/ 2026-10-28T21:02:16+00:00 https://revistasangre.com/es/2024/esteroides-versus-eltrombopag-para-el-tratamiento-de-primera-y-segunda-linea-de-la-trombocitopenia-inmune-en-adultos/ 2026-10-28T21:03:05+00:00 https://revistasangre.com/en/2024-en/volume-43-number-2/steroids-versus-eltrombopag-for-first-and-second-line-treatment-of-adult-immune-thrombocytopenia/ 2026-10-28T21:03:11+00:00 https://revistasangre.com/es/2024/el-papel-de-la-aferesis-en-el-manejo-de-los-sindromes-mieloproliferativos-cronicos-philadelphia-negativos-ante-el-desabastecimiento-de-farmacos/ 2026-10-28T21:03:53+00:00 https://revistasangre.com/en/2024-en/volume-43-number-2/the-role-of-apheresis-in-the-management-of-philadelphia-negative-chronic-myeloproliferative-syndromes-following-drug-shortages/ 2026-10-28T21:03:58+00:00 https://revistasangre.com/es/2024/a-proposito-de-las-terapias-rebalanceadoras-que-aporta-concizumab/ 2026-10-28T21:04:42+00:00 https://revistasangre.com/en/2024-en/volume-43-number-2/regarding-rebalancing-therapies-what-is-concizumab-contribution/ 2026-10-28T21:04:46+00:00 https://revistasangre.com/es/2024/proyecciones-de-la-incidencia-de-los-canceres-hematologicos-en-espana-2024/ 2026-10-28T21:06:17+00:00 https://revistasangre.com/en/2024-en/volume-43-number-3/projections-of-the-incidence-of-haematological-cancers-in-spain-2024/ 2026-10-28T21:06:23+00:00 https://revistasangre.com/es/2024/impacto-y-carga-de-la-enfermedad-en-hemofilia-moderada-y-grave-desde-la-perspectiva-del-paciente-y-de-enfermeria-estudio-nurses-who-care/ 2026-10-28T21:07:21+00:00 https://revistasangre.com/en/2024-en/volume-43-number-3/impact-and-disease-burden-in-moderate-and-severe-hemophilia-from-patient-and-nursing-perspective-the-nurses-who-care-study/ 2026-10-28T21:07:29+00:00 https://revistasangre.com/es/2024/estado-actual-del-diagnostico-y-el-tratamiento-de-la-hemoglobinuria-paroxistica-nocturna-2024/ 2026-10-28T21:08:06+00:00 https://revistasangre.com/en/2024-en/volume-43-number-3/current-status-of-diagnosis-and-treatment-of-nocturnal-paroxysmal-hemoglobinuria-2024/ 2026-10-28T21:08:11+00:00 https://revistasangre.com/es/2025/enfermedad-medible-residual-en-hematologia-un-objetivo-terapeutico/ 2026-10-28T21:09:49+00:00 https://revistasangre.com/es/2025/secuenciacion-de-tercera-generacion-en-el-diagnostico-hematologico/ 2026-10-28T21:10:27+00:00 https://revistasangre.com/es/2025/la-tecnologia-crispr-cas-y-su-aplicacion-en-la-clinica-medica/ 2026-10-28T22:03:54+00:00 https://revistasangre.com/es/2025/resultados-clinicos-de-la-terapia-genica/ 2026-10-28T22:07:27+00:00 https://revistasangre.com/es/2025/diagnostico-de-las-neoplasias-hematologicas-de-predisposicion-germinal/ 2026-10-28T22:08:04+00:00 https://revistasangre.com/es/2025/mielofibrosis-que-estan-aportando-los-nuevos-farmacos-en-la-practica-clinica/ 2026-10-28T22:08:52+00:00 https://revistasangre.com/es/2025/adolescente-de-13-anos-con-bicitopenia-y-adenopatias/ 2026-10-28T22:09:25+00:00 https://revistasangre.com/es/2025/recien-nacido-con-fiebre-y-leucocitosis/ 2026-10-28T22:09:56+00:00 https://revistasangre.com/es/2025/mujer-de-28-anos-con-lumbalgia-aguda-fiebre-y-pancitopenia/ 2026-10-28T22:10:41+00:00 https://revistasangre.com/es/2025/paciente-con-sindrome-de-vena-cava-superior/ 2026-10-28T22:11:20+00:00 https://revistasangre.com/es/2025/mujer-de-64-anos-con-hematomas-generalizados/ 2026-10-28T22:11:56+00:00 https://revistasangre.com/es/2025/varon-de-74-anos-con-antecedente-de-leucemia-mielomonocitica-cronica-que-presenta-bicitopenia-hepatoesplenomegalia-y-poliserositis-de-repeticion/ 2026-10-28T22:12:38+00:00 https://revistasangre.com/es/2025/caracteristicas-clinicas-y-epidemiologicas-de-las-leucemias-cronicas-en-una-cohorte-del-hospital-central-militar/ 2026-10-28T22:13:59+00:00 https://revistasangre.com/en/2025-en/volume-44-number-1/clinical-and-epidemiological-characteristics-of-chronic-leukemias-in-a-cohort-from-the-central-military-hospital/ 2026-10-28T22:14:04+00:00 https://revistasangre.com/es/2025/diagnostico-precoz-de-trombosis-venosa-profunda-en-pacientes-internados/ 2026-10-28T22:14:40+00:00 https://revistasangre.com/en/2025-en/volume-44-number-1/early-diagnosis-of-deep-vein-thrombosis-in-hospitalized-patients/ 2026-10-28T22:14:45+00:00 https://revistasangre.com/es/2025/utilizacion-de-los-cuidados-paliativos-en-pacientes-con-tumores-hematologicos-frente-a-pacientes-con-tumores-solidos-en-nuestro-medio-existen-diferencias-significativas/ 2026-10-28T22:15:16+00:00 https://revistasangre.com/en/2025-en/volume-44-number-1/use-of-palliative-care-in-patients-with-hematological-tumors-versus-patients-with-solid-tumors-in-our-setting-are-there-differences/ 2026-10-28T22:15:22+00:00 https://revistasangre.com/es/2025/guia-de-manejo-del-tratamiento-con-venetoclax-y-azacitidina-de-pacientes-con-leucemia-mieloblastica-aguda-no-tributarios-de-quimioterapia-intensiva/ 2026-10-28T22:15:54+00:00 https://revistasangre.com/en/2025-en/volume-44-number-1/management-guide-for-treatment-with-venetoclax-and-azacitidine-in-patients-with-acute-myeloid-leukemia-ineligible-for-intensive-chemotherapy/ 2026-10-28T22:15:59+00:00 https://revistasangre.com/es/2025/linfoma-linfoplasmocitico-recomendaciones-sobre-el-estudio-de-secuenciacion-masiva/ 2026-10-28T22:17:17+00:00 https://revistasangre.com/en/2025-en/volume-44-number-2/lymphoplasmacytic-lymphoma-recommendations-for-next-generation-sequencing/ 2026-10-28T22:17:23+00:00 https://revistasangre.com/es/2025/patrones-de-tratamiento-en-el-mundo-real-y-eficacia-comparativa-en-pacientes-no-candidatos-con-leucemia-mieloide-aguda-current-resultados-de-la-poblacion-espanola/ 2026-10-28T22:18:16+00:00 https://revistasangre.com/en/2025-en/volume-44-number-2/real-world-treatment-patterns-and-comparative-efficacy-in-unfit-patients-with-acute-myeloid-leukemia-current-results-of-the-spanish-population/ 2026-10-28T22:18:22+00:00 https://revistasangre.com/es/2025/es-aun-relevante-el-trasplante-de-progenitores-hematopoyeticos-en-la-nueva-era-de-la-inmunoterapia/ 2026-10-28T22:18:58+00:00 https://revistasangre.com/en/2025-en/volume-44-number-2/is-hematopoietic-stem-cell-transplantation-still-relevant-in-the-new-era-of-immunotherapy/ 2026-10-28T22:19:03+00:00 https://revistasangre.com/es/2025/sindromes-mielodisplasicos-recomendaciones-sobre-el-estudio-de-secuenciacion-masiva/ 2026-10-28T22:20:35+00:00 https://revistasangre.com/en/2025-en/volume-44-number-3/myelodysplastic-syndromes-recommendations-for-massive-sequencing-studies/ 2026-10-28T22:20:40+00:00 https://revistasangre.com/es/2025/linfoma-de-burkitt-recomendaciones-para-el-estudio-de-secuenciacion-masiva/ 2026-10-28T22:21:15+00:00 https://revistasangre.com/en/2025-en/volume-44-number-3/burkitt-lymphoma-recommendations-for-next-generation-sequencing/ 2026-10-28T22:21:26+00:00 https://revistasangre.com/es/2025/anticuerpos-biespecificos-para-el-tratamiento-del-mieloma-multiple-en-recaida-refractario-recomendaciones-de-expertos-para-la-administracion-en-los-centros-espanoles/ 2026-10-28T22:22:07+00:00 https://revistasangre.com/en/2025-en/volume-44-number-3/bispecific-monoclonal-antibodies-for-the-treatment-of-relapsed-refractory-multiple-myeloma-expert-recomendations-for-their-administration-in-spanish-centers/ 2026-10-28T22:22:12+00:00 https://revistasangre.com/es/2025/perspectiva-genealogica-identificacion-de-la-enfermedad-de-von-willebrand-tipo-2n-con-la-mutacion-homocigota-r816w-en-el-gen-vwf/ 2026-10-28T22:22:51+00:00 https://revistasangre.com/en/2025-en/volume-44-number-3/genealogical-insight-uncovering-type-2n-von-willebrand-disease-with-homozygous-r816w-mutation-in-the-vwf-gene/ 2026-10-28T22:22:55+00:00 https://revistasangre.com/es/2026/leucemia-linfoblastica-aguda-recomendaciones-sobre-el-estudio-de-secuenciacion-masiva/ 2026-10-28T22:24:41+00:00 https://revistasangre.com/en/2026-en/volume-45-number-1/acute-lymphoblastic-leukemia-recommendations-for-next-generation-sequencing/ 2026-10-28T22:24:47+00:00 https://revistasangre.com/es/2026/mieloma-multiple-recomendaciones-sobre-el-estudio-de-secuenciacion-masiva/ 2026-10-28T22:25:20+00:00 https://revistasangre.com/en/2026-en/volume-45-number-1/multiple-myeloma-recommendations-for-next-generation-sequencing/ 2026-10-28T22:25:26+00:00 https://revistasangre.com/es/2026/la-deficiencia-de-vitamina-b12-mas-alla-de-la-anemia-megaloblastica-papel-de-las-vias-alternativas-de-captacion-celular-de-vitamina-b12/ 2026-10-28T22:25:52+00:00 https://revistasangre.com/en/2026-en/volume-45-number-1/vitamin-b12-deficiency-beyond-megaloblastic-anemia-the-role-of-alternative-pathways-for-cellular-uptake-of-vitamin-b12/ 2026-10-28T22:25:58+00:00 https://revistasangre.com/es/2026/diagnostico-precoz-de-trombosis-venosa-profunda-en-pacientes-internados-2/ 2026-10-28T22:26:27+00:00 https://revistasangre.com/en/2026-en/volume-45-number-1/early-diagnosis-of-deep-vein-thrombosis-in-hospitalized-patients-2/ 2026-10-28T22:26:33+00:00 https://revistasangre.com/es/2026/terapia-renal-sustitutiva-en-pacientes-con-insuficiencia-renal-agudo-grave-secundario-a-rinon-de-mieloma-ventajas-del-uso-de-filtros-de-pmma/ 2026-10-28T22:32:34+00:00 https://revistasangre.com/en/2026-en/volume-45-number-2/renal-replacement-therapy-in-patients-with-acute-kidney-injury-due-to-cast-nephropathy-benefits-of-pmma-filters/ 2026-10-28T22:32:40+00:00 https://revistasangre.com/es/2026/abordaje-integral-de-la-hemoglobinuria-paroxistica-nocturna-para-una-correcta-identificacion-de-los-pacientes-que-podrian-beneficiarse-del-cambio-de-tratamiento-de-ic5-a-icp-consenso-de-opin/ 2026-10-28T22:33:25+00:00 https://revistasangre.com/en/2026-en/volume-45-number-2/comprehensive-approach-to-paroxysmal-nocturnal-hemoglobinuria-for-the-correct-identification-of-patients-who-may-benefit-from-switching-from-ic5-to-icp-a%c2%80%c2%93-expert-consensus-opinion/ 2026-10-28T22:33:31+00:00 https://revistasangre.com/es/2026/neoplasias-mieloproliferativas-recomendaciones-sobre-el-estudio-de-secuenciacion-masiva/ 2026-10-28T22:35:26+00:00 https://revistasangre.com/en/2026-en/volume-45-number-2/myeloproliferative-neoplasms-recommendations-for-next-generation-sequencing/ 2026-10-28T22:35:56+00:00 https://revistasangre.com/es/2026/linfoma-b-de-celulas-grandes-recomendaciones-para-el-estudio-de-secuenciacion-masiva/ 2026-10-28T22:37:05+00:00 https://revistasangre.com/en/2026-en/volume-45-number-2/large-b-cell-lymphoma-recommendations-for-next-generation-sequencing/ 2026-10-28T22:37:17+00:00 https://revistasangre.com/es/2026/linfoma-de-celulas-del-manto-recomendaciones-para-el-estudio-de-secuenciacion-masiva/ 2026-10-28T22:38:31+00:00 https://revistasangre.com/en/2026-en/volume-45-number-2/mantle-cell-lymphoma-recommendations-for-next-generation-sequencing/ 2026-10-28T22:38:37+00:00 https://revistasangre.com/es/2026/leucemia-linfatica-cronica-recomendaciones-para-el-estudio-de-secuenciacion-masiva/ 2026-10-28T22:39:29+00:00 https://revistasangre.com/en/2026-en/volume-45-number-2/chronic-lymphocytic-leukemia-recommendations-for-next-generation-sequencing/ 2026-10-28T22:39:37+00:00 https://revistasangre.com/es/2026/leucemia-mieloide-aguda-recomendaciones-sobre-el-estudio-de-secuenciacion-masiva/ 2026-10-28T22:40:48+00:00 https://revistasangre.com/en/2026-en/volume-45-number-2/acute-myeloid-leukemia-recommendations-for-next-generation-sequencing/ 2026-10-28T22:40:54+00:00 https://revistasangre.com/es/2026/linfoma-folicular-recomendaciones-para-el-estudio-de-secuenciacion-masiva/ 2026-10-28T22:43:18+00:00 https://revistasangre.com/en/2026-en/volume-45-number-3/follicular-lymphoma-recommendations-for-next-generation-sequencing/ 2026-10-28T22:43:24+00:00 https://revistasangre.com/es/2026/linfomas-de-celulas-t-recomendaciones-sobre-el-estudio-de-secuenciacion-masiva/ 2026-10-28T22:44:10+00:00 https://revistasangre.com/en/2026-en/volume-45-number-3/t-cell-lymphomas-recommendations-for-next-generation-sequencing/ 2026-10-28T22:44:16+00:00 https://revistasangre.com/es/2026/avatrombopag-mas-alla-de-la-ficha-tecnica-experiencia-de-un-centro/ 2026-10-28T22:44:46+00:00 https://revistasangre.com/en/2026-en/volume-45-number-3/avatrombopag-mas-alla-de-la-ficha-tecnica-experiencia-de-un-centro-2/ 2026-10-28T22:44:52+00:00 https://revistasangre.com/es/2026/recambio-plasmatico-terapeutico-rescate-para-la-anemia-hemolitica-grave-asociada-a-pylera/ 2026-10-28T22:45:22+00:00 https://revistasangre.com/en/2026-en/volume-45-number-3/therapeutic-plasma-exchange-rescue-for-severe-hemolytic-anemia-associated-with-pylera/ 2026-10-28T22:45:27+00:00 https://revistasangre.com/es/2026/estrategias-terapeuticas-en-llc-eficacia-y-seguridad-de-zanubrutinib-en-pacientes-con-arritmias-y-riesgo-hemorragico-informe-de-dos-casos/ 2026-10-28T22:45:59+00:00 https://revistasangre.com/en/2026-en/volume-45-number-3/therapeutic-strategies-in-chronic-lymphocytic-leukemia-efficacy-and-safety-of-zanubrutinib-in-patients-with-arrhythmias-and-hemorrhagic-risk-report-of-two-cases/ 2026-10-28T22:46:04+00:00 https://revistasangre.com/es/2026/desregulacion-hematologica-como-senal-de-errores-congenitos-de-la-inmunidad-sindrome-de-la-fosfatidilinositol-3-cinasa-delta-activada-apds-como-modelo/ 2026-10-28T22:46:49+00:00 https://revistasangre.com/en/2026-en/volume-45-number-3/hematologic-dysregulation-as-a-sign-of-inborn-errors-of-immunity-activated-pi3ki-syndrome-apds-as-a-model/ 2026-10-28T22:46:54+00:00 https://revistasangre.com/es/uncategorized-es/consenso-de-expertos-espanoles-sobre-el-marco-de-la-ebmt-de-2023-para-el-manejo-del-sindrome-de-obstruccion-sinusoidal-enfermedad-venooclusiva-en-adultos-estudio-delphi/ 2026-10-28T22:56:20+00:00 https://revistasangre.com/en/uncategorized-es-en/spanish-expert-agreement-with-the-2023-ebmt-framework-for-adult-sinusoidal-obstruction-syndrome-veno-occlusive-disease-management-a-delphi-study/ 2026-10-28T22:56:26+00:00 https://revistasangre.com/es/uncategorized-es/hemoglobinuria-paroxistica-nocturna-y-trasplante-hepatico-un-nuevo-paradigma-con-inhibidores-proximales-del-complemento/ 2026-10-28T23:03:50+00:00 https://revistasangre.com/en/uncategorized-es-en/paroxysmal-nocturnal-hemoglobinuria-and-liver-transplantation-a-new-paradigm-with-proximal-complement-inhibition/ 2026-10-28T23:04:13+00:00 https://revistasangre.com/es/uncategorized-es/linfomas-b-y-t-nk-recomendaciones-sobre-el-estudio-de-secuenciacion-masiva/ 2026-10-28T23:24:01+00:00 https://revistasangre.com/en/uncategorized-es-en/b-and-t-nk-lymphomas-recommendations-for-next-generation-sequencing/ 2026-10-28T23:24:16+00:00 https://revistasangre.com/es/uncategorized-es/linfoma-marginal-recomendaciones-sobre-el-estudio-de-secuenciacion-masiva/ 2026-10-28T23:31:48+00:00 https://revistasangre.com/en/uncategorized-es-en/marginal-zone-lymphoma-recommendations-for-next-generation-sequencing/ 2026-10-28T23:32:06+00:00